SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum

Go back to SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
(NASDAQ: SPRC) Delayed: 6.92 -0.05 (0.72%)
Previous Close $6.97    52 Week High
Open $6.90    52 Week Low
Day High $6.92    P/E N/A 
Day Low $6.55    EPS
Volume 6,737       

(NASDAQ: SPRC) Delayed: 6.92 -0.05 (0.72%)
Previous Close $6.97    52 Week High
Open $6.90    52 Week Low
Day High $6.92    P/E N/A 
Day Low $6.55    EPS
Volume 6,737